Hello Aditi-
Apart from properly documenting the change in your Change Management System, I would recommend utilizing the guidance in MDCG 2020-3, Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDD, to assess and justify the change to the device.
A letter to file similar to those done for FDA could work as a good 'cover letter' for the technical file as the changes can be summarized and then linked directly to the change control record. I like the decision trees in MDCG 2020-3 as they can be included as part of the assessment to show that all areas were considered.
It should also be noted that, while the change may be determined to be non-significant, agreements with your NB could require notification of the change.
------------------------------
Stephanie Chea Matias
Director, Quality Systems & Regulatory Affairs
United States
------------------------------
Original Message:
Sent: 15-Aug-2022 10:21
From: Aditi Kinikar
Subject: Documenting Non-significant changes for EU
Hello Regulatory folks!
How is everybody documenting 'non-significant' changes made to medical devices for the EU? Perhaps something similar to a Letter to File?
Thanks!
Aditi
------------------------------
Aditi Kinikar
Regulatory Specialist
United States
------------------------------